document.write('<div class="rss_box">');
document.write('<p class="rss_items">');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/09/does-amgen-pass-buffetts-test?fromrss=1"  target="feed">Does Amgen Pass Buffett\'s Test?</a></b>');
document.write('<br /><p>We\'d all like to invest as successfully as the legendary Warren Buffett. He calculates return on invested capital to help determine whether a company has an economic moat -- the ability to earn returns on its money beyond that money\'s cost.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/09/hewlett-packards-10-billion-spending-spree?fromrss=1"  target="feed">Hewlett-Packard\'s $10 Billion Spending Spree</a></b>');
document.write('<br /><p>Hewlett-Packard shareholders may have smiled to hear that the company has authorized a $10 billion stock buyback.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/09/amass-your-fortune-with-these-top-stocks?fromrss=1"  target="feed">Amass Your Fortune With These Top Stocks</a></b>');
document.write('<br /><p>You don\'t need theA investing acumen of Warren Buffett A or the riches of a trust fund baby to achieve financial success.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/09/biotech-stocks-alert?fromrss=1"  target="feed">Biotech Stocks ALERT</a></b>');
document.write('<br /><p>New York, NY-Gilead Sciences, Inc. slid 1.82% to $31.83 on over 19.20 million shares.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/drugmakers-may-lose-a-back-door-for-drug-approval?fromrss=1"  target="feed">Drugmakers May Lose a Back Door for Drug Approval</a></b>');
document.write('<br /><p>Drugmakers\' bag of tricks for getting drugs approved may be getting smaller. A new report out from the General Accountability Office says that the Food and Drug Administration is cracking down on non-inferiority clinical trials.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/analysis-amgen-holding-billions-overseas-looks-for-deals?fromrss=1"  target="feed">Analysis: Amgen, holding billions overseas, looks for deals</a></b>');
document.write('<br /><p>Amgen Inc , the world\'s largest biotechnology company, is cash rich and on the prowl for acquisitions -- possibly companies outside of the United States that would expand its international footprint.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/top-heavy-pharmaceuticals?fromrss=1"  target="feed">Top-Heavy Pharmaceuticals</a></b>');
document.write('<br /><p>Investors have been cautioned for decades not to put all their eggs into one basket, and numerous studies have shown savvy diversification can increase portfolio returns while simultaneously reducing risk.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/best-value-picks-in-biotech-now?fromrss=1"  target="feed">Best Value Picks in Biotech Now</a></b>');
document.write('<br /><p>Morgan Joseph likes Spectrum, Isis, Onyx and Amgen. Morgan Joseph PRICING PRESSURE IN Europe has generally resulted in lower-than-expected revenue and earnings from drug and revenue-generating biotech companies.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/could-amgen-be-a-multibagger?fromrss=1"  target="feed">Could Amgen Be a Multibagger?</a></b>');
document.write('<br /><p>Investor Chuck Akre recently shared his secret to stock success with a group of Fools: He simply looks for 100-baggers. After we politely snickered, Chuck explained that while he hasn\'t actually found a 100-bagger yet, he does believe that companies that can compound shareholder capital at high rates have the best chance of generating phenomenal ...</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/biotech-stocks-in-spotlight?fromrss=1"  target="feed">Biotech Stocks in Spotlight</a></b>');
document.write('<br /><p>New York, NY -Jazz Pharmaceuticals, Inc. plunged 22.19% to $7.96 on over 8.44 million shares.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/geoeye-named-one-of-fortune-magazines-100-fastest-growing-companies?fromrss=1"  target="feed">GeoEye Named One of Fortune Magazine\'s \'100 Fastest-Growing Companies\'</a></b>');
document.write('<br /><p>GeoEye, Inc. , a premier provider of superior satellite and aerial-based geospatial information and services, announced today it has been ranked 84th on FORTUNE Magazine\'s 2010 \"100 Fastest-Growing Companies\" list.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/sadif-analytics-rates-repligen-corporation-as-a-below-average-quality?fromrss=1"  target="feed">SADIF Analytics rates Repligen Corporation as a below average quality ...</a></b>');
document.write('<br /><p>SADIF Analytics rates Repligen Corporation as a below average quality company with a positive outlook.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/biotechnology-in-canada-new-research-report-available-at-fast-market-research?fromrss=1"  target="feed">Biotechnology in Canada: New research report available at Fast Market Research</a></b>');
document.write('<br /><p>It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/dr-reddys-launches-darbepoetin-alfa-in-india-under-the-brand-name?fromrss=1"  target="feed">Dr Reddy\'s Launches Darbepoetin Alfa In India Under The Brand Name...</a></b>');
document.write('<br /><p>Main Category: Blood / Hematology Also Included In: Pharma Industry / Biotech Industry Dr.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/three-ways-to-brace-for-a-double-dip-recession-recession-proof-stocks?fromrss=1"  target="feed">Three Ways to Brace for a Double-Dip Recession: Recession-Proof Stocks</a></b>');
document.write('<br /><p>Today we conclude our series on bracing for a double-dip recession . In Part I of this investment series, \" Three Ways to Brace for a Double-Dip Recession: Going for the Gold ,\" we discussed ways investors could safeguard against the imminent decline of the U.S. dollar by buying gold.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/citigroup-inc?fromrss=1"  target="feed">Citigroup, Inc</a></b>');
document.write('<br /><p>Analysts Ratings: Citigroup, Inc Reiterates \"Buy\" Rating on Amgen, Inc Citigroup, Inc analysts maintained a \"buy\" rating on shares of Amgen, Inc with a price target of $64.00 in a research note to investors on Thursday.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/with-muscle-building-treatment-mice-live-longer-even-as-tumors-grow-amgen-study?fromrss=1"  target="feed">With Muscle-Building Treatment, Mice Live Longer Even as Tumors Grow, Amgen Study</a></b>');
document.write('<br /><p>With Muscle-Building Treatment, Mice Live Longer Even as Tumors Grow, Amgen Study 8/20/2010 ScienceDaily a \' In the vast majority of patients with advanced cancer, their muscles will gradually waste away for reasons that have never been well understood.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/3-stocks-priced-for-corporate-buyouts?fromrss=1"  target="feed">3 Stocks Priced for Corporate Buyouts</a></b>');
document.write('<br /><p>That\'s a modest pace, compared with the frantic deal-making of 2006 and 2007, when full-year M&amp;A volume topped $3.5 trillion and $4 trillion, respectively.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/biotech-industry-group-spent-2m-lobbying-in-2q?fromrss=1"  target="feed">Biotech industry group spent $2M lobbying in 2Q</a></b>');
document.write('<br /><p>The Biotechnology Industry Organization spent just over $2 million lobbying the federal government in the second quarter on health care, agricultural, and economic issues affecting the biotech industry.</p>');
document.write('</li>');
document.write('<b><p class="rss_item"><a class="rss_item" href="http://www.topix.net/com/amgn/2010/08/amgen-spent-1-92m-lobbying-government-in-2q?fromrss=1"  target="feed">Amgen spent $1.92M lobbying government in 2Q</a></b>');
document.write('<br /><p>Biotech drugmaker Amgen Inc. spent $1.92 million on lobbying the federal government in the second quarter, according to a recent filing.</p>');
document.write('</li>');
document.write('</ul></div>');
document.close();